Finding the best partner for your biotech – Optimizing study design, partnering, and identifying investors

Sponsored by: Parexel International

Vivek Mittal, PhD, Partner and Managing Director, Health Advances, United States
Gary Cheng, Vice President, Health Advances, Hong Kong
Liuqing Yang, Senior Director, Medical Sciences, Parexel International, China

Wednesday - November 18, 2020 / 9am India Standard Time/ 11:30am China Standard Time/ 12:30pm Japan Standard Time/ 14:30pm Australian Eastern Standard Time
Free Event

Reserve your spot

Biotech companies often facing challenges on finding investors or partners. The problem is not where to find them but how to identify the best fit.    Based on our decades of experience, insight, analytical rigor, and objective perspective, we provide innovative solutions to our clients.

In this webinar, we will discuss what works and what does not for your study design and how to optimize it;  address issues from commercial aspects and why it should be considered early in your clinical development;   share parameters for identifying partners for transactions; and prepare a pitch deck for your investors to achieve success.

Experts will focus on the following topics:

  • Optimizing study design for your biotech
  • Strategic considerations for clinical Development and partnering
  • Searching for new investors

About the Sponsors

Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do. Headquartered near Boston, Massachusetts and in Durham, North Carolina, and supporting clients in more than 100 countries, our almost 20,000 employees are united by one simple fact. We care. We’re not just the people with brains, we’re the people with heart.

For more information please visit

Comments are closed.